AdvanceD Medicare Prescription Payment Plan Solution
Significantly Reduce Patient Collection Risk
Klyre gives you the flexibility to launch an interest free patient advance solution to address the CMS IRA MP3 2025 requirement. Klyre’s nimble platform allows payors and PBMs to incorporate compliant features that dramatically reduce patient collections risk and exposure.
SKU Level Spend Conrols
Klyre’s unique SKU level payment controls ensure that funds being advanced to patients are used exclusively on allowable Part D formulary medications. Klyre’s AdanceD solution provides:
Greater Program Control
Improved Patient Experience
Enhanced Data Reconciliation
The IRA Medicare Prescription Payment Plan Requirement Starts January 2025
Our solution is fee free to patients and provides a turnkey advance to purchase approved items at 65,000+ Pharmacies and Physicians Offices. Customers can budget payments over time according to the CMS requirements and the Klyre controlled rule set provide installment options for 100% of patients needs.